Category survey

Targeting Lewy Body Specific Pathology Using Biomarkers Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

ARIC Neurocognitive Study (ARIC-NCS) 1 of 5 Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia. Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Dementia with Lewy Bodies Consortium Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

VCID Biomarkers Coordinating Center Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Risk Factors for Stroke and Cognitive Decline in a Tri-Ethnic Region Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Underlying Mechanisms of Vascular Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Understanding the role of MAPT in Parkinsonian disorders Investments > €500k United States of America Neurodegenerative disease in general|Parkinson’s disease & PD-related disorders 2016    

Bilingual Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

A Tailored Technology Intervention for Diverse Family Caregivers of AD Patients Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Semantic Memory and Language Learning in Alzheimers Disease and Semantic Dementi Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The Role of Palliative Care Interventions to Reduce Circadian Rhythm Disorders in Persons with Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

New York City Hispanic Dementia Caregiver Research Program (NHiRP) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Determinants of Midlife & Longitudinal Change in Cognitive Function: CARDIA Study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Brain aging and treatment response in geriatric depression Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Effects of tDCS on spoken and written production in Primary Progressive Aphasia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Combining AD Epitope Vaccine with Innate Immunity Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Frontotemporal Dementia Induced Pluripotent Stem Cell Consortium Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

CNS TAU KINETICS IN ALZHEIMERS DISEASE Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Environmental Determinants of Pathological Brain Aging in WHI Memory Studies Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Integrating Quality Control: Studies of UBQLN2 in Age-Related Neurodegeneration Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

ARIC Neurocognitive Study (ARIC-NCS) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Partnership for Magnetic Resonance Spectroscopy Biomarker Development Investments > €500k United States of America Alzheimer’s disease & other dementias|Spinocerebellar ataxia (SCA) 2016    

Mechanisms of Prion Protein Toxicity Investments > €500k United States of America Prion disease 2016    

Presenilins in the hippocampal network and Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5 Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

INVESTIGATIONS OF DEMENTIA IN PARKINSON DISEASE Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Nucleocytoplasmic transport and nuclear pore disruption in ALS/FTD Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Characterizing Cognitive Decline in Late Life Depression: The ADNI-D Project Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

ApoE4 and mechanisms of diffuse white matter injury Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Neurobiology and Therapeutic Potential of Klotho Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Small vessel disease biomarkers in a longitudinally-followed stroke-belt cohort Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Alzheimers Disease, Genes, and Pesticide Use in the Agricultural Health Study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Para-Vascular Basis of Small Vessel Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model. Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Integrating Neurophysiological Views of the Aging Visual System Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Epigenetic and phenotypic effects of arsenic: impacts on cognition and AD Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Mechanisms of abeta induced dysfunction in hippocampal neuronal circuitry Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Sleep Disordered Breathing in normal elderly and risk for Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Environmental copper exposure and its impact on microglial Abeta clearance Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Hemorheological Factors in Cerebral Ischemia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Super-Resolution Microscopy of Small Quantum Dots to Elucidate the Mechanisms of Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Cerebrovascular Contributions to Brain Aging and Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Intersection of alpha synuclein and tau contributions to neurotoxicity Investments > €500k United States of America Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

GBA pathway markers for Lewy body dementias Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

CNS and Plasma Amyloid–Beta Kinetics in Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Aggression Prevention Training for Caregivers of Persons with Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Development, Validation, and Application of an Imaging based CVD Scale Investments > €500k United States of America Alzheimer’s disease & other dementias 2016